Wilson Sonsini Goodrich & Rosati advised Wu Capital on the deal. Korro Bio, Inc., a biotech startup founded in 2018, announced a $91.5 million Series A…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
